Combining trazodone with other serotonergic agents (e.g., SSRIs, SNRIs, MAOIs) increases the risk of serotonin syndrome. If a combination is clinically necessary, it must be carefully managed and monitored by a prescriber.
Weight changes are not a prominent side effect of trazodone. Some patients report modest weight gain, but evidence is limited; lifestyle factors usually play a larger role.
Most patients notice reduced sleep latency within 1-2 weeks of nightly low-dose use. Full therapeutic effect on sleep may require several weeks of consistent dosing.
Trazodone is not classified as habit-forming. Physical dependence is rare, but abrupt discontinuation after long-term use may cause rebound insomnia, so tapering is advisable.
Desyrel tablets typically bear a numeric imprint corresponding to the strength (e.g., “25” for 25 mg) and the brand logo; exact imprint details can vary by manufacturer and country.
Yes, provided you carry the original prescription label and a copy of the prescription. Some countries require a doctor’s note for controlled medications; check local regulations before travel.
Both trazodone and first-generation antihistamines (e.g., diphenhydramine) cause sedation. Concomitant use may intensify drowsiness, so caution is recommended.
Yes, trazodone is marketed as a generic product by several UK pharmacies. The active ingredient, dosage strength, and therapeutic effect are identical to the branded Desyrel.
If you remember the missed bedtime dose at least 6 hours before the next scheduled dose, you may take it. If it is closer to the next dose time, skip the missed dose and resume your regular schedule-do not double up.
Trazodone can cause orthostatic hypotension, which may augment the blood-pressure-lowering effect of antihypertensives. Monitor blood pressure regularly and discuss any dizziness with your clinician.
Desyrel is a prescription-only medication marketed in the United Kingdom under the brand name Desyrel. It contains trazodone as its active ingredient. Trazodone belongs to the antidepressant class known as serotonin-modulating agents and is also prescribed off-label as a sleeping aid. It is supplied as oral pills in strengths of 25 mg, 50 mg, and 100 mg.
Trazodone exerts its therapeutic effect primarily by influencing the serotonin system. It acts as a serotonin 5-HT₂A receptor antagonist and a weak serotonin reuptake inhibitor. By blocking 5-HT₂A receptors, trazodone reduces excessive serotonergic stimulation that can contribute to anxiety, insomnia, and depressive symptoms. Its modest reuptake inhibition modestly increases extracellular serotonin, further supporting mood elevation.
Because of these actions, trazodone also has sedative properties: antagonism of histamine H₁ receptors and blockade of α₁-adrenergic receptors promote drowsiness, especially at lower doses. The onset of clinical effect typically occurs within 1-2 hours after ingestion, with peak plasma concentrations reached around 2 hours. The drug’s half-life ranges from 5 to 13 hours, allowing once-daily dosing for depression and bedtime dosing for insomnia.
Desyrel (trazodone) is licensed in the UK for the treatment of major depressive disorder in adults when other antidepressants are unsuitable or ineffective. The medication is indicated for patients who require an oral antidepressant with a different pharmacological profile from selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants.
Although not a formally approved indication, clinicians frequently prescribe low-dose trazodone (often 25 mg-100 mg at bedtime) for insomnia. This practice is supported by clinical experience and guideline statements that acknowledge trazodone’s sedative effect at sub-antidepressant doses. Off-label use should be supervised by a healthcare professional, and patients should be informed that the indication is not formally approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
All dosing must be individualized by the prescribing clinician; the above ranges reflect typical practice and are not a substitute for professional guidance.
This article provides educational information about Desyrel and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.